@article{102580, keywords = {Benznidazole, Chagas Cardiomyopathy, Chagas disease, Posaconazole, Trypanosoma cruzi}, author = {Crespillo-Andújar C and Perez-Molina JA}, title = {The importance of long-term follow-up data in Chagas disease: new challenges for old paradigms}, abstract = {
Chagas disease affects >7 million people globally, with >400 000 of them residing outside endemic regions. Approximately 70 000 of these cases are in Spain, making it the second non-endemic country with the highest estimated number of cases, after the United States [1]. In recent decades, improvements in living conditions, globalization, and increased population mobility have significantly shaped the epidemiology of Chagas disease beyond endemic areas. Consequently, long-term follow-up data from cohorts in endemic regions—while historically valuable—may no longer accurately reflect the current landscape of the disease
}, year = {2025}, journal = {Clinical Microbiology and Infection}, publisher = {Elsevier BV}, issn = {1198-743X}, url = {https://www.clinicalmicrobiologyandinfection.org/article/S1198-743X(25)00311-8/abstract}, doi = {10.1016/j.cmi.2025.06.024}, language = {eng}, }